Understanding Your Laboratory Test: What It Is, Why It Is Done, and What the Results Mean
A blood test performed on newborns to detect rare metabolic disorders by measuring acylcarnitine levels in the blood.
{"Screens for inherited metabolic disorders affecting how the body breaks down fats","Collected from a small blood sample, usually within 24-48 hours of birth","Abnormal results require follow-up testing to confirm or rule out conditions","Early detection allows for early treatment, which can prevent serious complications","This test is part of routine newborn screening in most countries"}
Key facts at a glance
- LOINC
- 58088-6
- Short code
- Acylcarnitine DBS-Imp
- Synonyms
- Acylcarnitine DBS-Imp
- Category
- chemistry
- Sample
- serum
- Container
- Red-top tube (SST)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Specimen volume
- 5 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
This test is a laboratory analysis performed on a sample of your blood, urine, or other body fluid or tissue. It helps your healthcare provider gather important information about how your body is functioning and whether there are any signs of illness or disease that may need further attention.
The acylcarnitine newborn screen is a blood test that measures the levels of different acylcarnitines in a baby's blood. Acylcarnitines are substances that help the body transport fatty acids into cells where they can be used for energy. This test helps detect rare genetic metabolic disorders that affect how the body processes fats and amino acids.
Your doctor may order this test to help diagnose a medical condition, monitor an ongoing health problem, screen for disease before symptoms appear, or check how well a treatment is working. It can also be part of a routine checkup to evaluate your overall health and detect changes early.
This test is part of routine newborn screening programs. It helps identify babies with metabolic disorders such as fatty acid oxidation disorders (like MCAD deficiency), organic acidemias (like propionic acidemia), and other inherited conditions. These disorders can cause serious health problems if not treated early, but early detection and treatment can prevent complications and improve outcomes.
A trained healthcare professional will collect a small sample, most often by drawing blood from a vein in your arm using a thin needle, or by asking you to provide a urine sample. The procedure usually takes only a few minutes and causes little more than a brief pinch or sting before the sample is sent to the laboratory.
A small blood sample is taken from your baby's heel (heel stick) within the first 24-48 hours of life. The blood is placed on a special filter paper and sent to a laboratory for analysis. The test is quick and the heel stick may cause brief discomfort, but it is generally well-tolerated by newborns.
Your results are compared with standard reference ranges that show what is considered typical for healthy people. Values within these ranges are generally reassuring, while results that are higher or lower than normal may point to a condition that needs closer evaluation. Your provider will explain your specific numbers and whether any follow-up testing or treatment is needed.
The laboratory measures various types of acylcarnitines, each represented by a code (like C0, C2, C3, C4, C5, C8, C10, C12, C14, C16, C18). Abnormal levels of specific acylcarnitines can indicate different metabolic disorders. Your healthcare provider will explain which acylcarnitine levels are abnormal and what this may mean for your baby.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
The acylcarnitine newborn screen can detect over 30 different metabolic disorders. These include medium-chain acyl-CoA dehydrogenase (MCAD) deficiency, which is one of the most common fatty acid oxidation disorders, as well as other conditions like propionic acidemia, methylmalonic acidemia, and isovaleric acidemia. Early detection allows for prompt treatment with special diets, medications, and avoiding fasting, which can prevent life-threatening complications such as metabolic crisis, developmental delays, and organ damage.
Frequently asked questions
Is this test mandatory?
What happens if the test results are abnormal?
Can my baby have this disorder even if no one in our family has it?
Will my baby need special care if a disorder is detected?
When will I get the results?
Sources
- 1
- 2
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy